Report Overview:
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 101 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
This report aims to provide a comprehensive presentation of the global market for Nanotechnology in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology in Healthcare. This report contains market size and forecasts of Nanotechnology in Healthcare in global, including the following market information:
Market Value:
The global Nanotechnology in Healthcare market was valued at US$ 211810 million in 2023 and is projected to reach US$ 259910 million by 2030, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
CAGR of 3.0%
(2022 – 2029)
By Types:
•Nanomedicine
•Nano Medical Devices
•Nano Diagnosis
By Applications:
Anticancer
CNS Product
Key players include:
•Amgen
•Teva Pharmaceuticals
•Abbott
•UCB
•Roche
•Celgene
•Sanofi
•Including or excluding key companies relevant to your analysis.
